The association between pSTAT3 positivity and OS was evaluated using the 10%, 30% or 80% cut-off for PTCL-NOS, AITL, and ALK-negative ALCLs cohorts of PTCL patients (Fig. 2a). The gene discussed is ALK; the disease is angioimmunoblastic T-cell lymphoma.